Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

Konstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, Neil P. Jerome, Jessica K.R. Boult, Matthew D. Blackledge, Fernando Carceller, Alexander Koers, Giuseppe Barone, Andrew D.J. Pearson, Lucas Moreno, John Anderson, Neil Sebire, Kieran McHugh, Dow-Mu Koh, Louis Chesler, Yinyin Yuan, Simon P. Robinson, Yann Jamin

Cancer Res (2020) 80 (16): 3424–3435.

https://doi.org/10.1158/0008-5472.CAN-20-0133

Published: 14 August 2020

View article titled, Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

Includes: Supplementary data

Journal Articles

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Cancer Res (2019) 79 (11): 2978–2991.

https://doi.org/10.1158/0008-5472.CAN-18-3412

Published: 03 June 2019

View article titled, MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Includes: Supplementary data

Journal Articles

Abstract 491: Tumor response to cabozantinib in the TH-MYCN GEM model of neuroblastoma

Gilberto S. Almeida, Philippa King, Yann Jamin, Albert Hallsworth, Hannah Webber, Sergey Popov, Andrew D.J. Pearson, Louis Chesler, Simon P. Robinson

Cancer Res (2015) 75 (15_Supplement): 491.

https://doi.org/10.1158/1538-7445.AM2015-491

Published: 01 August 2015

View article titled, Abstract 491: Tumor response to cabozantinib in the TH-MYCN GEM model of neuroblastoma

Journal Articles

Abstract 5037: Intrinsic susceptibility magnetic resonance imaging identifies tumors with ALKF1174L mutation in transgenic murine models of high-risk neuroblastoma.

Yann Jamin, Laura Glass, Albert Hallsworth, Rani E. George, Dow-Mu Koh, Andrew D.J. Pearson, Louis Chesler, Simon P. Robinson

Cancer Res (2013) 73 (8_Supplement): 5037.

https://doi.org/10.1158/1538-7445.AM2013-5037

Published: 15 April 2013

View article titled, Abstract 5037: Intrinsic susceptibility magnetic resonance imaging identifies tumors with ALKF1174L mutation in transgenic murine models of high-risk neuroblastoma.

Journal Articles

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated HOX/Stem Cell Gene Signature

Nathalie Gaspar, Lynley Marshall, Lara Perryman, Dorine A. Bax, Suzanne E. Little, Marta Viana-Pereira, Swee Y. Sharp, Gilles Vassal, Andrew D.J. Pearson, Rui M. Reis, Darren Hargrave, Paul Workman, Chris Jones

Cancer Res (2010) 70 (22): 9243–9252.

https://doi.org/10.1158/0008-5472.CAN-10-1250

Published: 14 November 2010

View article titled, MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated HOX/Stem Cell Gene Signature

Journal Articles

Increased Frequency of Aberrations in the p53/MDM2/p14^ARF Pathway in Neuroblastoma Cell Lines Established at Relapse

Jane Carr, Emma Bell, Andrew D.J. Pearson, Ursula R. Kees, Helen Beris, John Lunec, Deborah A. Tweddle

Cancer Res (2006) 66 (4): 2138–2145.

https://doi.org/10.1158/0008-5472.CAN-05-2623

Published: 17 February 2006

View article titled, Increased Frequency of Aberrations in the p53/MDM2/p14ARF Pathway in Neuroblastoma Cell Lines Established at Relapse

NARROW

Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Abstract 491: Tumor response to cabozantinib in the TH-MYCN GEM model of neuroblastoma

Abstract 5037: Intrinsic susceptibility magnetic resonance imaging identifies tumors with ALKF1174L mutation in transgenic murine models of high-risk neuroblastoma.

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated HOX/Stem Cell Gene Signature

Increased Frequency of Aberrations in the p53/MDM2/p14^ARF Pathway in Neuroblastoma Cell Lines Established at Relapse

Email alerts

AACR Journals

Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Abstract 491: Tumor response to cabozantinib in the TH-MYCN GEM model of neuroblastoma

Abstract 5037: Intrinsic susceptibility magnetic resonance imaging identifies tumors with ALKF1174L mutation in transgenic murine models of high-risk neuroblastoma.

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated HOX/Stem Cell Gene Signature

Increased Frequency of Aberrations in the p53/MDM2/p14ARF Pathway in Neuroblastoma Cell Lines Established at Relapse

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

Increased Frequency of Aberrations in the p53/MDM2/p14^ARF Pathway in Neuroblastoma Cell Lines Established at Relapse